Glycogen metabolism
Metabolic coupling between astrocytes and neurons
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Glossary
- ATP=
- adenosine triphosphate;
- cAMP=
- cyclic adenosine monophosphate;
- GBE=
- glycogen branching enzyme;
- GSK=
- glycogen synthase kinase;
- PTG=
- protein targeting to glycogen.
Brain glycogen metabolism provides a typical example of metabolic coupling between neurons and astrocytes. Glycogen is almost exclusively localized in astrocytes and serves as an endogenous source of energy for these cells and for neurons. Neural activity leads to release of glutamate and other neurotransmitters that trigger mobilization of energy from glycogen in astrocytes. Glycogenolysis in astrocytes leads to the production of lactate, which serves as an energy substrate for the active neurons. Although the functional role of glycogen in the brain is incompletely understood, there is experimental evidence that glycogen is able to sustain neuronal activity during energy deprivation or in the setting of hypoxia, ischemia, hypoglycemia, or seizures. Whereas neurons also have the enzymatic machinery to synthesize glycogen, in normal conditions this process is actively inhibited, and this prevents glycogen- triggered damage of these cells. Abnormal glycogen metabolism has been typically associated with muscle disorders, but may also underlie some disorders affecting the CNS. Inability to inhibit glycogen synthesis in neurons is the basis for Lafora disease and impaired activity of glycogen branching enzyme occurs in adult polyglucosan body disease. The focus of this short review is on some physiologic aspects of brain glycogen metabolism and their clinical correlations. These topics have been comprehensively reviewed elsewhere.1–7
OVERVIEW OF GLYCOGEN METABOLISM IN THE CNS
Glycogen metabolism in astrocytes.
In adult brain, glycogen is predominantly present in astrocytes. Glycogen is a spherical and highly branched polymer comprising up to approximately 53,000 glycosyl units. It is synthesized from a core consisting of a peptide called glycogenin and proglycogen, which serves as a stable intermediate that is converted into macroglycogen, the storage form of glycogen.8,9
Glycogen synthesis from glucose depends on the activity of glycogen synthase, which catalyzes formation of α-1,4-glycosidic linkage of the polymer, and glycogen branching enzyme, which introduces the α-1,6-glycosidic branch points. Degradation occurs in the cytosol through …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Clinical/Scientific Notes
Lafora bodies in skeletal muscle are fiber type specificJ. Turnbull, J.-M. Girard, N. Pencea et al.Neurology, March 30, 2011 -
Clinical/Scientific Notes
Phosphorylation prevents polyglucosan transport in Lafora diseaseJean-Marie Girard, Scellig S.D. Stone, Hannes Lohi et al.Neurology, May 23, 2012 -
Neurology Clinical Pathological Conference
A 63-year-old woman with urinary incontinence and progressive gait disorderA. Lossos, C. J. Klein, K. M. McEvoy et al.Neurology, May 04, 2009 -
Editorials
Lafora progressive myoclonus epilepsyGlycogen storage disease vs neurodegenerative diseaseAntonio V. Delgado-Escueta et al.Neurology, May 23, 2012